• Citer

A first-in-human phase i and pharmacokinetic study of CP-4126 (CO-101), a nucleoside analogue, in patients with advanced solid tumours

par Venugopal, Balaji;Awada, Ahmad ;Evans, Thomas Ronald Jeffrey;Dueland, Svein;Hendlisz, Alain ;Rasch, Wenche;Hernes, K.;Hagen, S.;Aamdal, Steinar
Référence Cancer chemotherapy and pharmacology, 76, 4, page (785-792)
Publication Publié, 2015-10

Article révisé par les pairs

• Détails
• Contenu

Titre:	A first-in-human phase i and pharmacokinetic study of CP-4126 (CO-101), a nucleoside analogue, in patients with advanced solid tumours
Auteur:	Venugopal, Balaji; Awada, Ahmad; Evans, Thomas Ronald Jeffrey; Dueland, Svein; Hendlisz, Alain; Rasch, Wenche; Hernes, K.; Hagen, S.; Aamdal, Steinar
Informations sur la publication:	Cancer chemotherapy and pharmacology, 76, 4, page (785-792)
Statut de publication:	Publié, 2015-10
Sujet CREF:	Cancérologie
	Pharmacologie
	Toxicologie pharmaceutique
Mots-clés:	CO-101
	CP-4126
	Gemcitabine
	hENT1
	Nucleoside transporter
	Pancreatic cancer
	Pharmacokinetics
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0344-5704
	info:doi/10.1007/s00280-015-2846-0
	info:scp/84942194429
	info:pmid/26289594